Rac1 targeting suppresses human non-small cell lung adenocarcinoma cancer stem cell activity

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• The cancer stem cell (CSC) theory highlights a small cell fraction responsible for tumor initiation and propagation.
• Molecular mechanisms regulating CSCs are not fully understood, hindering effective cancer therapies.
• Rac1, a Rho GTPase, is involved in cancer cell proliferation and invasion.

Purpose of the Study:

• To investigate the role of Rac1 in tumor initiation and metastasis of human non-small cell lung adenocarcinoma (NSCLA).
• To determine if Rac1 is critical for the function of cancer stem cells (CSCs) in NSCLA.

Main Methods:

• Utilized shRNA to knockdown Rac1 in NSCLA cell lines and patient specimens.
• Isolated side population (SP) cells representing putative CSCs.
• Assessed tumorigenic activities including invasion, proliferation, anchorage-independent growth, sphere formation, and lung colonization.
• Quantified Rac1-GTP levels in SP and non-SP cells.
• Administered pharmacological or shRNA targeting of Rac1.

Main Results:

• Rac1 knockdown significantly suppressed tumorigenic activities in NSCLA cells and patient specimens.
• NSCLA side population (SP) cells showed elevated Rac1-GTP, enhanced migration, invasion, and increased tumor initiation and lung colonization.
• CSCs activity was also present in non-SP cells.
• Targeting Rac1 inhibited tumorigenic activities in both SP and non-SP NSCLA cells.

Conclusions:

• Rac1 plays a critical role in the tumorigenic activities and metastasis of NSCLA.
• Rac1 is a potential therapeutic target for NSCLA, as its blockade can inhibit CSC proliferation and metastasis.
• Therapeutic strategies should consider targeting both SP and non-SP cells in NSCLA.